Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Early AVR bests ‘watchful waiting’ in asymptomatic patients

Patients with severe but asymptomatic aortic stenosis have better survival two and three years later if an aortic valve replacement (AVR) is initially recommended instead of a “watchful waiting” approach, according to a single-center study published in The Annals of Thoracic Surgery.

Thumbnail

Ambulance transport policies for stroke patients differ by state

While accident victims in the U.S. are uniformly taken directly to the most advanced trauma center nearby, the protocols for where to shuttle stroke patients vary widely by state, according to a recent article by Stateline.

Antibiotic-eluting envelop reduces risk of CIED infections by 40%

A mesh envelope embedded with antibiotics cut the risk of major device-related infections by 40 percent when placed around cardiac implantable electronic devices (CIEDs) like pacemakers and defibrillators, researchers reported in the New England Journal of Medicine.

FDA approves implantable device for CRT-ineligible HF patients

The FDA has approved the Optimizer Smart system as an implantable treatment option for heart failure patients with left ventricular ejection fraction between 25 and 45 percent who aren’t candidates for cardiac resynchronization therapy (CRT).

Thumbnail

Two-drug combos built around amlodipine control BP in African study

In the largest-ever randomized trial of antihypertensive drug treatment in sub-Saharan Africa, two medication combinations including the long-acting calcium channel blocker amlodipine outperformed a third two-drug combination featuring a diuretic and an angiotensin-converting-enzyme (ACE) inhibitor.

Thumbnail

Renal denervation sustains BP reduction for 6 months in sham-controlled trial

Hypertensive patients from the RADIANCE-HTN SOLO trial who received renal denervation sustained a lower blood pressure through six months compared to participants randomized to a sham procedure, despite being placed on fewer antihypertensive medications during follow-up.

Thumbnail

The newest player in remote cardiovascular monitoring: A toilet seat?

Researchers from the Rochester Institute of Technology are leveraging “natural processes” to provide insights into heart health with a toilet seat-based cardiovascular monitoring system.

Thumbnail

CardioMEMS sensor cuts HF-related hospitalizations by 58%

A post-FDA approval study of Abbott’s CardioMEMS heart failure sensor found the device reduced HF-related hospitalizations by 58 percent in a trial group of 1,200 patients, researchers reported at this year’s American College of Cardiology symposium in New Orleans.